Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 31,694 | 30,678 | 35,397 | 29,772 | 29,697 |
| Cost of Goods | 14,351 | 16,936 | 14,200 | 8,649 | 5,951 |
| Gross Profit | 17,343 | 13,742 | 21,197 | 21,123 | 23,746 |
| Operating Expenses | 25,621 | 24,214 | 14,303 | 16,970 | 12,648 |
| Operating Income | -7,927 | -9,536 | 7,094 | 4,802 | 12,049 |
| Other Income | -228 | -169 | 279 | 360 | 482 |
| Pre-tax Income | -8,155 | -9,705 | 7,373 | 5,162 | 12,531 |
| Income Tax | -1,744 | -1,997 | 1,580 | 1,111 | 3,331 |
| Net Income Continuous | -6,411 | -7,708 | 5,793 | 4,051 | 9,200 |
| Net Income | $-6,411 | $-7,708 | $5,793 | $4,051 | $9,200 |
| EPS Basic Total Ops | -0.45 | -0.54 | 0.41 | 0.28 | 0.65 |
| EPS Basic Continuous Ops | -0.45 | -0.54 | 0.41 | 0.28 | 0.65 |
| EPS Diluted Total Ops | -0.45 | -0.54 | 0.40 | 0.27 | 0.64 |
| EPS Diluted Continuous Ops | -0.45 | -0.54 | 0.40 | 0.27 | 0.64 |
| EBITDA(a) | $-2,175 | $-3,089 | $30,398 | $7,106 | $13,269 |